R03BB01 • ipratropium bromide • Respiratory system | Other drugs for obstructive airway diseases, inhalants | Anticholinergics
Ipratropium bromide is a bronchodilator used for the treatment of chronic obstructive pulmonary disease (COPD) and bronchial asthma. It works by blocking muscarinic receptors, relaxing airway muscles, and improving breathing.
The medication is administered as an aerosol or nebulizer solution, as directed by a doctor. It is important to follow the recommended dose to avoid side effects.
Side effects may include dry mouth, cough, throat irritation, or dizziness. In rare cases, severe allergic reactions or breathing difficulties may occur.
Ipratropium bromide is not recommended for patients with hypersensitivity to this medication or other anticholinergics.
Substance: ipratropium bromide
Date of last drug list: 01-06-2025
Commercial code: W65226001
Concentration: 20mcg / dose
Pharmaceutical form: pressurized inhalation solution
Quantity: 1
Product type: generic
Price: 24.99 RON
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.
Manufacturer: CIPLA (EU) LIMITED - MAREA BRITANIE
Holder: AMRING FARMA S.R.L. - ROMANIA
Number: 9131/2016/01
Shelf life: 2 years
Price
Copayment
Patient
24.99 RON
12.40 RON
12.59 RON